1. Home
  2. ASM vs TNDM Comparison

ASM vs TNDM Comparison

Compare ASM & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avino Silver & Gold Mines Ltd. (Canada)

ASM

Avino Silver & Gold Mines Ltd. (Canada)

N/A

Current Price

$7.53

Market Cap

1.3B

ML Signal

N/A

Logo Tandem Diabetes Care Inc.

TNDM

Tandem Diabetes Care Inc.

N/A

Current Price

$20.62

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASM
TNDM
Founded
1968
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
ASM
TNDM
Price
$7.53
$20.62
Analyst Decision
Strong Buy
Buy
Analyst Count
3
19
Target Price
$8.18
$28.00
AVG Volume (30 Days)
4.4M
1.8M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,014,736,000.00
Revenue This Year
$53.35
$8.11
Revenue Next Year
$34.26
$11.85
P/E Ratio
$67.93
N/A
Revenue Growth
N/A
7.93
52 Week Low
$4.00
$11.46
52 Week High
$11.99
$29.65

Technical Indicators

Market Signals
Indicator
ASM
TNDM
Relative Strength Index (RSI) 60.57 46.97
Support Level $5.40 $19.70
Resistance Level $8.12 $20.79
Average True Range (ATR) 0.38 1.11
MACD -0.02 -0.40
Stochastic Oscillator 84.35 0.47

Price Performance

Historical Comparison
ASM
TNDM

About ASM Avino Silver & Gold Mines Ltd. (Canada)

Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: